Gene: RIMOC1
Official Full Name: RAB7A interacting MON1-CCZ1 complex subunit 1provided by HGNC
Gene Summary: Involved in mitophagy. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14515 | RIMOC1 Knockout cell line (HeLa) | Human | RIMOC1 | 1:3~1:6 | Negative | Online Inquiry |
KO14516 | RIMOC1 Knockout cell line (HCT 116) | Human | RIMOC1 | 1:2~1:4 | Negative | Online Inquiry |
KO14517 | RIMOC1 Knockout cell line (HEK293) | Human | RIMOC1 | 1:3~1:6 | Negative | Online Inquiry |
KO14518 | RIMOC1 Knockout cell line (A549) | Human | RIMOC1 | 1:3~1:4 | Negative | Online Inquiry |
RIMOC1 Gene Knockout Cell Lines are specialized cellular models that have been engineered to have a deletion of the RIMOC1 gene, which is implicated in critical neurobiological functions and synaptic regulation. These knockout cell lines serve as essential tools for researchers to investigate the physiological and pathological roles of the RIMOC1 gene, enabling a deep understanding of synaptic disorders and providing insights into potential therapeutic targets.
The key functions of these cell lines stem from their ability to mimic specific genetic conditions relevant to various neurological diseases. By eliminating the RIMOC1 gene, researchers can study the cascading effects on neurotransmitter release, synaptic plasticity, and neuronal signaling pathways. These cell lines allow for the examination of cellular responses to pharmacological agents and facilitate the screening of compounds aimed at restoring normal function in affected neurons.
The scientific importance of RIMOC1 Gene Knockout Cell Lines extends to their applications in both fundamental research and translational medicine. They provide a robust platform for investigating the molecular mechanisms underlying synaptic dysfunction associated with cognitive disorders, neurodegenerative diseases, and psychiatric conditions. Furthermore, these cell lines can be utilized in drug development programs, enhancing the ability to screen for candidate therapeutics that target synaptic pathology.
What sets RIMOC1 Gene Knockout Cell Lines apart from alternative models is their precise genetic modification, which allows for a consistent and reproducible study of RIMOC1 function in a controlled environment. Unlike primary neurons that may exhibit variability and limited lifespan, these knockout cell lines offer an abundant and stable resource for long-term studies, maximizing experimental efficiency and reliability.
For researchers and clinicians aiming to deepen their understanding of neural mechanisms or explore novel treatment avenues, RIMOC1 Gene Knockout Cell Lines are invaluable tools that facilitate groundbreaking discoveries. Their availability allows for advanced exploration of neurobiology while minimizing the limitations often encountered with other cell line models.
Our company prides itself on a commitment to producing high-quality, meticulously characterized biological products, ensuring that researchers have access to reliable tools necessary for their innovative work in genetics, neuroscience, and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.